Skip to main content
. 2023 Aug 31;2023(8):CD013074. doi: 10.1002/14651858.CD013074.pub2

ACTRN12620000408987.

Study name Structured exercise prograM to reduce Fatigue In patients receiving dialysis: a preference‐stratified adaptive Trial (M‐FIT)
Methods Study design
  • RCT

  • Duration of follow‐up: 36 weeks (12 weeks treatment + additional 24 weeks follow‐up)

Participants Study characteristics
  • Country: Australia

  • Setting: multicentre

  • Inclusion criteria

    • On maintenance HD or PD (> 3 months) with a life expectancy of > 12 months

    • ≥ 18 years

    • Willing to participate and provide informed consent

    • Able to speak, read and write English

    • Access to a smartphone or tablet with Internet access

    • Ability to carry out movements at intensity level 1 of all 3 exercise prescriptions and the stretches in the control arm (as assessed by the site exercise professional)

  • Exclusion criteria

    • Known cardiovascular disease that places the participant at an unacceptable risk of untoward events occurring during exercise training (as deemed by the treating physician)

    • Have received or are expected to receive a kidney transplant within 12 months

    • Currently meeting the physical activity guidelines as assessed by Active Australia Survey/National Health survey (150 min/week of moderate‐intensity aerobic (cardio) activity and 2 sessions/week of resistance training)

Interventions Intervention group 1
  • Walking (3 non‐consecutive days/week, (~60 min/session); will complete a series of stretches after their walking sessions)


Intervention group 2
  • Resistance training (3 non‐consecutive days/week (~60 min/session); consists of a core set of 8 exercises, option to include 2 exercises to facilitate individualisation of exercise prescription, includes warm‐up and cool‐down stretches. e.g. sit to stand, wall push up, standing horizontal TheraBand row, etc)


Intervention group 3
  • Combination of aerobic (cardio) and resistance training (3 non‐consecutive days/week (~60 minutes/session); e.g. aerobic/cardio: walking, cycling etc e.g. resistance: sit to stand, wall push ups etc, which are home‐based exercises delivered through a mobile application)


Control group
  • Same process as the exercise arms; however, access on the M‐FIT application will be restricted to a low‐intensity stretching routine only (no access to exercise sessions or videos). They will be doing 3 non‐consecutive days of stretches e.g. shoulder stretch, hip flexor stretch etc for about 10 mins at home, via the app and complete trial outcome assessment questionnaires


Co‐interventions
  • Not reported

Outcomes Planned outcomes
  • Fatigue

    • Pittsburgh Fatigability Scale questionnaires: baseline, 4, 8, 12, 36 weeks

    • FACIT‐Fatigue: SONG‐HD Fatigue: baseline, 4, 8, 12, 36 weeks

    • FACIT Fatigue Scale: baseline, 4, 8, 12 weeks

  • Physical activity

    • Wrist‐worn activity monitor (ActiGraph): baseline, at week 12 and week 36

  • Neuromuscular fitness: baseline, at week 12 and week 36

  • Heart rate: at week 12 and week 36

  • Death

  • Vascular access: up to 36 weeks

  • PD infections: up to 36 weeks

  • Technique survival: up to 36 weeks

  • Exercise adherence

    • Study‐specific self‐report questionnaires to be completed for every exercise session: up to 12 weeks

  • Hospitalisation: up to 36 weeks

  • HRQoL

    • EQ‐5D‐5: baseline, 4, 8, 12, 36 weeks

  • Cost‐effectiveness and cost‐utility: up to 36 weeks

  • Frailty

    • Fried Frailty Index: baseline, at week 12 and week 36

  • Mood

    • HADS: baseline, 4, 8, 12, 36 weeks

  • Social participation

    • Ability to Participate in Social Roles and Activities (PROMIS‐SF) questionnaire: baseline, 4, 8, 12, 36 weeks

  • BMI: baseline, 12, 36 weeks

  • Exercise capacity

    • 6MWT: baseline, 12, 36 weeks

  • Balance

    • Tinetti balance test (score): baseline, 12, 36 weeks

  • Sleep

    • Wrist‐worn activity monitor (ActiGraph): baseline, at week 12 and week 36

  • Process evaluation (for patients and staff)

    • Qualitative semi‐structured interviews: immediately post‐intervention and another 12 months post‐intervention

  • Usability of the M‐FIT mobile application

    • Modified system usability scale (mSUS): at week 36

Starting date March 2020
Contact information Allison Jaure
Phone: +61 2 9845 1467
Email: allison.jaure@sydney.edu.au
Notes ClinicalTrials.gov Identifier: ACTRN12620000408987. Funding: Australian Department of Health. Recruitment status: Not yet recruiting